questions for the agm, page-13

Info from the AGM

50 pounds per treatment (Euro equivalent for EU) for VitroGro

2X revenue per sale of VitroGrow to TIS under the deal announced today, compared to a traditional "vanilla" licensing deal

Mediterranean countries will be "side stepped" for approximately 1-2 years to avoid the current problems they are experiencing.

In the USA it is easier to get a reimbursement for a biologic than a device.

80% of sales of VitroGrow are expected to occur outside of the hospital setting i.e. clinic setting.

14 micrograms of VitroGrow per treatment. Current production of 350L of VitroGrow per production cycle. Each production cycle takes approximately 3 months. Each production cycle will produce "millions" of treatments.